Ambu stock falls after UBS cuts its target to DKK 72

Published on 09/16/2026 at 22:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock fell nearly 3 percent on September 15, 2026 after UBS cut its target to DKK 72 from DKK 96. The company had already flagged a margin target that UBS said looks hard to reach.

Fotorealistische Medizintechnik-Fertigung von Einweg-Endoskopen im Reinraum — Ambu A/S (DK0060946788) zeigt fotorealistisch moderne Medizintechnik-Fertigung von Einweg-Endoskopen in steriler Reinraumumgebung, Illustration mit AI erstellt.

Ambu stock (DK0060946788) fell nearly 3 percent on the Copenhagen exchange on September 15, 2026 after UBS cut its 12 month price target to DKK 72 from DKK 96 and downgraded the shares to neutral.

UBS turns more cautious

According to Ad Hoc News, UBS shifted its recommendation on Ambu to neutral from buy on September 15, 2026 and cut the 12 month target to DKK 72 from DKK 96. The same report said UBS sees the margin target as difficult to reach under current operating conditions.

That matters for investors because the new target is 25 percent below the old one, and the downgrade landed after a session in which the shares closed close to 3 percent lower.

FY26 numbers still frame the story

At the annual general meeting on September 16, 2026, Amber Enterprises reported FY26 consolidated revenue of INR 12,186 crore and operating EBITDA of INR 970 crore, while the electronics division posted revenue of INR 3,268 crore and EBITDA of INR 287 crore.

The company also said the electronics division's revenue rose 49 percent year on year, while its EBITDA increased 89 percent, a gap that points to operating leverage in the unit mix.

Stock level on September 16

On September 16, 2026, Ambu shares were still trading with the September 15 downgrade in view, and the latest session move left the stock nearly 3 percent lower on the Copenhagen exchange.